Use of botulinum toxin type A for the treatment of masseteric muscle hypertrophy

Osman Kursat Arikan; Funda Uysal Tan; Tuba Kendi; Can Koc

doi:10.2310/7070.2005.4108

Use of botulinum toxin type A for the treatment of masseteric muscle hypertrophy

Osman Kursat Arikan, Funda Uysal Tan, Tuba Kendi, Can Koc

Radiology

Research output: Contribution to journal › Article › peer-review

9 Scopus citations

Abstract

We investigated the effectiveness of botulinum toxin A intramuscular injection for the management of masseteric muscle hypertrophy. Five patients with masseteric muscle hypertrophy were treated with botulinum toxin A (Dysport, Beaufour Ipsen, France). Clinical photographs were obtained before and between 3 and 6 months after application. Four patients are pleased with their present facial appearance. However, one patient reported mild discomfort about his appearance. Neither local nor general adverse effects were noted. Botulinum toxin A is a safe, easy-to-use, and effective nonsurgical option in the management of masseteric muscle hypertrophy. Its use is associated with a high degree of patient and physician satisfaction.

Original language	English (US)
Pages (from-to)	40-43
Number of pages	4
Journal	Journal of Otolaryngology
Volume	35
Issue number	1
DOIs	https://doi.org/10.2310/7070.2005.4108
State	Published - Feb 1 2006

Keywords

Botulinum toxin A
Masseteric muscle hypertrophy
Treatment

ASJC Scopus subject areas

Medicine(all)

Access to Document

10.2310/7070.2005.4108

Fingerprint Dive into the research topics of 'Use of botulinum toxin type A for the treatment of masseteric muscle hypertrophy'. Together they form a unique fingerprint.

Cite this

@article{be1735a6ddbd49a8a67fee2230edb5b7,

title = "Use of botulinum toxin type A for the treatment of masseteric muscle hypertrophy",

abstract = "We investigated the effectiveness of botulinum toxin A intramuscular injection for the management of masseteric muscle hypertrophy. Five patients with masseteric muscle hypertrophy were treated with botulinum toxin A (Dysport, Beaufour Ipsen, France). Clinical photographs were obtained before and between 3 and 6 months after application. Four patients are pleased with their present facial appearance. However, one patient reported mild discomfort about his appearance. Neither local nor general adverse effects were noted. Botulinum toxin A is a safe, easy-to-use, and effective nonsurgical option in the management of masseteric muscle hypertrophy. Its use is associated with a high degree of patient and physician satisfaction.",

keywords = "Botulinum toxin A, Masseteric muscle hypertrophy, Treatment",

author = "Arikan, {Osman Kursat} and Tan, {Funda Uysal} and Tuba Kendi and Can Koc",

year = "2006",

month = feb,

day = "1",

doi = "10.2310/7070.2005.4108",

language = "English (US)",

volume = "35",

pages = "40--43",

journal = "Journal of Otolaryngology - Head and Neck Surgery",

issn = "1916-0208",

publisher = "Decker Publishing",

number = "1",

}

TY - JOUR

T1 - Use of botulinum toxin type A for the treatment of masseteric muscle hypertrophy

AU - Arikan, Osman Kursat

AU - Tan, Funda Uysal

AU - Kendi, Tuba

AU - Koc, Can

PY - 2006/2/1

Y1 - 2006/2/1

N2 - We investigated the effectiveness of botulinum toxin A intramuscular injection for the management of masseteric muscle hypertrophy. Five patients with masseteric muscle hypertrophy were treated with botulinum toxin A (Dysport, Beaufour Ipsen, France). Clinical photographs were obtained before and between 3 and 6 months after application. Four patients are pleased with their present facial appearance. However, one patient reported mild discomfort about his appearance. Neither local nor general adverse effects were noted. Botulinum toxin A is a safe, easy-to-use, and effective nonsurgical option in the management of masseteric muscle hypertrophy. Its use is associated with a high degree of patient and physician satisfaction.

AB - We investigated the effectiveness of botulinum toxin A intramuscular injection for the management of masseteric muscle hypertrophy. Five patients with masseteric muscle hypertrophy were treated with botulinum toxin A (Dysport, Beaufour Ipsen, France). Clinical photographs were obtained before and between 3 and 6 months after application. Four patients are pleased with their present facial appearance. However, one patient reported mild discomfort about his appearance. Neither local nor general adverse effects were noted. Botulinum toxin A is a safe, easy-to-use, and effective nonsurgical option in the management of masseteric muscle hypertrophy. Its use is associated with a high degree of patient and physician satisfaction.

KW - Botulinum toxin A

KW - Masseteric muscle hypertrophy

KW - Treatment

UR - http://www.scopus.com/inward/record.url?scp=33645033602&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33645033602&partnerID=8YFLogxK

U2 - 10.2310/7070.2005.4108

DO - 10.2310/7070.2005.4108

M3 - Article

C2 - 16527016

AN - SCOPUS:33645033602

VL - 35

SP - 40

EP - 43

JO - Journal of Otolaryngology - Head and Neck Surgery

JF - Journal of Otolaryngology - Head and Neck Surgery

SN - 1916-0208

IS - 1

ER -